BCYC

Bicycle Therapeutics PLC

Price

$3.68

return (12m)

-46.97%

p/e

-1.35

p/bv

0.50

DIVIDEND YIELD

0.00%

BCYC price

Bicycle Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BCYC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-15.90%

3 months

-8.13%

1 year

-46.97%

2 years

-85.59%

5 years

-91.25%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BCYC

Valuation

P/E

-1.35

Sector -3.50

Industry -3.50

P/BV

0.50

Sector 2.02

Industry 2.02

P/Revenue (PSR)

4.19

Sector 2.01

Industry 2.01

EV/EBITDA

5.16

Sector -214.99

Industry -214.99

EV/EBIT

5.05

Sector -47.59

Industry -47.59

P/EBITDA

-1.40

Sector -21.41

Industry -21.41

P/EBIT

-1.36

Sector -28.65

Industry -28.65

P/Total Assets

0.42

Sector 1.19

Industry 1.19

P/Net Current Assets

0.54

Sector -11.97

Industry -11.97

P/Working Capital

0.49

Sector -167.95

Industry -167.95

EPS

-2.73

Sector -1.81

Industry -1.81

BVPS

7.31

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-7,811.13%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-7,980.76%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-37.32%

Sector -56.04%

Industry -56.04%

ROA

-31.39%

Sector -60.31%

Industry -60.31%

ROIC

-361.82%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

12.08

Sector 2.89

Industry 2.89

Net Debt / EBITDA

10.38

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

10.16

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.00

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.84

Sector 0.46

Industry 0.46

Liabilities/Assets

0.16

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

39.23%

Sector -

Industry -

5Y Earnings CAGR

23.30%

Sector -

Industry -

Fundamentals BCYC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BCYC Bicycle Therapeutics PLC	$3.68	-46.89%	0.00%	-1.35	0.50	-37.32%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BCYC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Bicycle Therapeutics

Bicycle Therapeutics PLC

Average Investor10 user rating

4.0 (1 people)

United States

17 years

Founded: 2009

2019

Time since IPO - 7 years

87

Employees

Bicycle Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $256.53 million, with shareholders equity totaling $510.26 million.

The company employs approximately 87 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Bicycle Therapeutics PLC reported $61.21 million in revenue, generating net income of $-190.41 million.

Key financial metrics include a P/E ratio of -1.35, a price-to-book (P/B) ratio of 0.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BCYC.

Market cap

$256.53 million

Net worth

$510.26 million

$510,255,000.00

Assets

$606.58 million

$606,578,000.00

Total Shares Outstanding

69.80 million

69,804,000

Average Daily Trading Volume

$344.10 Thousand

$344,095.72

Sector

Health Care

Industry

Biotechnology

BCYC

BCYC revenue and profits

Financial Results BCYC

DRAG THE FRAME TO SEE MORE DATA

BCYC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Bicycle Therapeutics (BCYC) today?

A cotação de Bicycle Therapeutics (BCYC) hoje está em US$ 3.68, com uma variação de -46.97% em relação ao último ano. A cotação de Bicycle Therapeutics (BCYC) iniciou o ano negociando na casa dos US$ 7.08 e hoje está em US$ 3.68. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Bicycle Therapeutics (BCYC) e dados de ações do Ibovespa e mercados internacionais.

Quando Bicycle Therapeutics (BCYC) paga dividendos?

Bicycle Therapeutics (BCYC) não distribuiu dividendos no último ano.

Is Bicycle Therapeutics (BCYC) a good investment?

Atualmente, Bicycle Therapeutics (BCYC) está cotada a US$ 3.68, com um P/L de -1.35, representando um desvio de -425% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -46.97 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -46.97%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Bicycle Therapeutics (BCYC) stock?

Investir em ações de Bicycle Therapeutics (BCYC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Bicycle Therapeutics (BCYC) yield today?

A rentabilidade de Bicycle Therapeutics (BCYC) foi de -15.90% no último mês, -46.97% no último ano e -91.25% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Bicycle Therapeutics (BCYC) hoje, o investimento total seria de US$ 367.50, com base na cotação atual de US$ 3.68.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 194.89
Em 5 anos: US$ 32.16
Em 10 anos: US$ 367.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BCYC

Bicycle Therapeutics PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BCYC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BCYC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Bicycle Therapeutics

Bicycle Therapeutics PLC

United States

17 years

2019

87

PROFIT X PRICE BCYC

Financial Results BCYC

BCYC cash flow

Asset, Revenue and Profit Growth - BCYC

BCYC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions